Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Pramlintide approval date?Generic brand for latisse?Campath litigation germany?Brenzavvy discontinuation?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) first received FDA approval in 2014 for cancer immunotherapy [1]. Sources: [1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514
Other Questions About Keytruda :